1. Home
  2. OLED vs TLX Comparison

OLED vs TLX Comparison

Compare OLED & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Display Corporation

OLED

Universal Display Corporation

SELL

Current Price

$85.31

Market Cap

3.4B

Sector

Technology

ML Signal

SELL

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

SELL

Current Price

$8.86

Market Cap

3.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OLED
TLX
Founded
1985
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
OLED
TLX
Price
$85.31
$8.86
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
★ $110.50
$19.71
AVG Volume (30 Days)
★ 704.0K
308.3K
Earning Date
10-28-2026
02-18-2027
Dividend Yield
★ 2.35%
N/A
EPS Growth
★ 9.25
N/A
EPS
★ 3.52
N/A
Revenue
★ $650,611,000.00
N/A
Revenue This Year
N/A
$16.83
Revenue Next Year
$6.60
$13.81
P/E Ratio
★ $24.16
$150.33
Revenue Growth
★ 0.45
N/A
52 Week Low
$70.77
$6.28
52 Week High
$134.60
$13.11

Technical Indicators

Market Signals
Indicator
OLED
TLX
Relative Strength Index (RSI) 48.05 37.80
Support Level $84.30 $8.69
Resistance Level $94.98 $9.83
Average True Range (ATR) 3.91 0.24
MACD -0.48 0.01
Stochastic Oscillator 27.12 1.79

Price Performance

Historical Comparison
OLED
TLX

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. The large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix is a developer of radiopharmaceuticals. Radiopharmaceuticals are specialized drugs containing radioactive isotopes, which are used in both diagnosing and treating cancer. At low doses, these drugs bind to a specific cancer cell and can be visualized through PET imaging. With high doses, they can deliver targeted treatment. Telix has a pipeline of both diagnostics and therapeutics in development. Its pipeline is focused on urologic oncology (prostate, kidney and bladder), neuro-oncology (glioma), musculoskeletal oncology and hematology. Currently, most of the firm's revenue comes from its Illuccix prostate cancer imaging/diagnostic agent.

Share on Social Networks: